Bio-Matrix Scientific Group, Inc.
Bio-Matrix Scientific Group in Joint Venture with Therinject and Entest BioMedical for New Immuno-Therapeutic Cancer Vaccine
Published in Blood Weekly, August 27th, 2009
The LOI, which is subject to the execution of a definitive agreement, contemplates the providing by BMSN of facilities and infrastructure to be utilized by both parties for the development of immuno-therapeutic treatments for cancer. Initially, BMSN and Therinject intend to focus on the veterinary market, looking to treat animals with tumors while...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-08-27)
More Articles from Blood Weekly
- Wiley-Blackwell
Studies reveal hepatitis C virus carriers experience substantial increase in mortality - Worcester Polytechnic Institute
Reprogramming human cells without inserting genes - World Journal of Gastroenterology
Metabolic bone disease in cirrhosis patients - Artificial Oxygen
Researchers from Kumamoto University publish new studies and findings in the area of artificial oxygen - Autoimmune Hemolytic Anemia
Studies from E. Sigler et al add new findings in the area of autoimmune hemolytic anemia - Clinical Trial Research
Study data from University of North Carolina, Gene Therapy Center provide new insights into clinical trial research - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
